Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Infect Genet Evol. 2013 Aug 17;20:78–82. doi: 10.1016/j.meegid.2013.08.008

Table 1.

The characteristics of HIV positive, non-heavily exposed HIV seronegative subjects (non-HESNs), HESNs and unexposed IDUs.

Co-variates HIV infected IDUs N = 172 HIV uninfected IDUs N = 173

Non-HESNs N = 68 HESNs N = 20 Unexposed N = 85
Gender
Male (n; %) 133; 77 58; 85 15; 75 66; 78
Age
Years [median (IQR)] 30 (27–33) 32 (24–37) 28 (24–33) 29 (24–33)
Duration of IVDU
Years [median (IQR)] 12.0 (10.0–15.0) 12.0 (7.0–14.0) 9.5 (4.5–14.5) 9.0 (4.8–12.3)
Receptive syringe sharinga
Yes 133; 77% 68; 100% 20; 100% 0
Receptive syringes sharing during last six monthsb
Never (n; %) 96; 56 41; 60 0 85; 100
<Once a month (n; %) 35; 20 27; 40 0 0
≥Once a month (n; %)b 41; 24 0 20; 100 0
HCV serostatus
HCV+ (n; %) 169; 98 59; 87 16; 80 62; 73
HBV serostatusc
HBV+ (n; %) 141; 89 43; 72 9; 56 39; 57
Dual infection
HCV+/HBV+ (n; %) 140; 81 42; 62 8; 40 35; 41

Note: IQR – interquartile range.

a

Syringe sharing is categorized as persons who had ever injected with syringes that had been used by somebody else (receptive sharing).

b

Comprises the frequencies: 1–3 times a month (n = 14), once a week (n = 2), 2–3 times a week (n = 2), 4–6 times a week (n = 1) and once a day (n = 1).

c

Of HIV positive IDUs, non-HESNs, HESNs and unexposed 13, 9, 4 and 17 subjects, respectively, were vaccinated.